APAC Whole Exome Sequencing Market - Industry Trends and Forecast to 2029
Asia-Pacific whole exome sequencing (WES) market is projected to register a substantial CAGR of 18.9% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.
Market Segmentation
Whole Exome Sequencing (WES) Market, By Component (Second generation sequencing and Third-Generation sequencing), Product and Service (systems, kits and services), Application (Drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others ), End User (pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others), Distribution Channel (direct trade, retail sales and others), Industry Trends and Forecast to 2029.
Some of the major factors contributing to the growth of the Asia-Pacific Whole Exome Sequencing (WES) market are:
• Growing usage of targeted sequencing methods
• Increase in the adoption of whole exome sequencing (WES)
Asia-Pacific Whole Exome Sequencing (WES) market is categorized into four notable segment which is Component, Product and Service, Application, End User and Distribution Channel.
• On the basis of component, the global whole exome sequencing (WES) market is segmented into second generation sequencing and third-generation sequencing.
• On the basis of Product and Service, the global whole exome sequencing (WES) market is segmented into systems, kits and services.
• On the basis of Application, the global whole exome sequencing (WES) market is segmented into drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others.
• On the basis of End user, the global whole exome sequencing (WES) market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others.
• On the basis of Distribution Channel, the global whole exome sequencing (WES) market is segmented into direct trade, retail sales and others.
Market Players
The key market players for Asia-Pacific whole exome sequencing (WES) market are listed below:
• Meridian
• Merck KGaA
• SOPHiA GENETICS
• Azenta U.S. Inc.
• CD Genomics
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook